CLDI icon

Calidi Biotherapeutics

35 hedge funds and large institutions have $3.09M invested in Calidi Biotherapeutics in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 6 closing their positions.

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
9
Reduced
4
Closed
6
Calls
Puts
$9K
Net Calls
-$9K
Net Calls Change
-$9K
Name Holding Trade Value Shares
Change
Shares
Change %
EWM
26
Evermay Wealth Management
Virginia
$3.59K
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$3K
TRCT
28
Tower Research Capital (TRC)
New York
$2.9K +$2.9K +426 New
BC
29
Barrett & Company
Rhode Island
$1.98K
Morgan Stanley
30
Morgan Stanley
New York
$1.14K -$286 -42 -20%
TCM
31
Tradewinds Capital Management
Washington
$567
CFO
32
CVA Family Office
Colorado
$283
SS
33
SBI Securities
Japan
$170 +$170 +25 New
BlackRock
34
BlackRock
New York
$147
Bank of America
35
Bank of America
North Carolina
$126 -$458 -69 -78%
UBS Group
36
UBS Group
Switzerland
$1 -$10.1K -733 Closed
Millennium Management
37
Millennium Management
New York
-$157K -11,345 Closed
Jane Street
38
Jane Street
New York
-$38.5K -2,786 Closed
Goldman Sachs
39
Goldman Sachs
New York
-$20.1K -1,459 Closed
HF
40
HRT Financial
New York
-$18K -1,313 Closed
IA
41
IFP Advisors
Florida
-$4.03K -292 Closed